WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
Spillway Gates Opened at Table Rock Dam
Man Found in Table Rock Lake Identified
College of the Ozarks Graduates Receives Recognition
How Did The Hollister School District Make The Transition in Leadership Work?
Flood Warnings Remain as Rain Pauses